About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Psyco Quality of Life and Procreation BRCA1/2 | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT05857670

Psyco Quality of Life and Procreation BRCA1/2

Women with breast and/or ovarian cancer or with a family history carried these pathologies can makeo genetic counseling in order to investigate whether they are carriers of the BRCA1/2 genetic mutatio...

Lead sponsor: Regina Elena Cancer Institute•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Anita Caruso

CONTACT

+39 06 52665332 anita.caruso@ifo.it

Sponsors

Lead Sponsor

Regina Elena Cancer Institute

Age

25 - 45 years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•Women with BRCA1/2 mutation affected or not by breast neoplasm
•Women with BRCA1/2 mutation affected or not by breast neoplasm and with at least a son/daughter
•Women with at list middle school diploma
•Women available to do interviews

Exclusion Criteria

•Women with other oncological pathology
•Women with cognitive deficient and/or inability to comply to the requirements of the study

Related studies

HER2-PET: Predicting T-DXd Efficacy and HER2 Heterogeneity

NCT07586215 · Breast Cancer Metastatic

RC48-ADC in HER2-low Advanced Breast Cancer

NCT05831878 · Advanced Breast Cancer

RECRUITINGPhase 2

Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer

NCT06525766 · Anatomic Stage IV Breast Cancer AJCC v8, Estrogen-receptor-positive Breast Cancer, and more

RECRUITINGPhase 4

A Randomized, Self-controlled Post-marketing Clinical Study on the Comparison of Shengbai Oral Liquid and Leucogen Tablets in the Treatment of Moderate Neutropenia Caused by Anti-tumor Drugs in Breast Cancer Patients

NCT07578064 · Breast Cancer, Bone Marrow Suppression

RECRUITINGPhase 2

To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer

NCT07368998 · Breast Cancer

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 1, 2024Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment200

Start dateMay 2022

Last updatedFeb 1, 2024

Condition

Breast Cancer Genetic Predisposition

Locations shown

"Regina Elena" National Cancer Institute

Rome

Università dell'Insubria

Varese

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 1, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions